Literature DB >> 26078556

Exclusive enteral nutrition in children with Crohn's disease.

Andrew S Day1, Robert N Lopez1.   

Abstract

Exclusive enteral nutrition involves the use of a complete liquid diet, with the exclusion of normal dietary components for a defined period of time, as a therapeutic measure to induce remission in active Crohn's disease (CD). This very efficacious approach leads to high rates of remission, especially in children and adolescents newly diagnosed with CD. This intervention also results in mucosal healing, nutritional improvements and enhanced bone health. Whilst several recent studies have provided further elaboration of the roles of exclusive enteral nutrition in the management of CD, other reports have provided new understanding of the mechanisms by which this intervention acts.

Entities:  

Keywords:  Children; Crohn’s disease; Exclusive enteral nutrition; Mechanisms; Nutrition; Outcomes

Mesh:

Year:  2015        PMID: 26078556      PMCID: PMC4462720          DOI: 10.3748/wjg.v21.i22.6809

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  53 in total

1.  International survey of enteral nutrition protocols used in children with Crohn's disease.

Authors:  Kylie E Whitten; Paula Rogers; Chee Keith Y Ooi; Andrew S Day
Journal:  J Dig Dis       Date:  2012-02       Impact factor: 2.325

2.  Refeeding syndrome following exclusive enteral nutritional treatment in Crohn disease.

Authors:  Anthony K Akobeng; Adrian G Thomas
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-09       Impact factor: 2.839

Review 3.  Enteral nutritional therapy for induction of remission in Crohn's disease.

Authors:  M Zachos; M Tondeur; A M Griffiths
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Exclusive enteral nutrition in the treatment of children with Crohn's disease in Sweden: a questionnaire survey.

Authors:  Josefin M Gråfors; Thomas H Casswall
Journal:  Acta Paediatr       Date:  2011-02-22       Impact factor: 2.299

5.  Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria.

Authors: 
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-07       Impact factor: 2.839

6.  Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.

Authors:  M Azcue; M Rashid; A Griffiths; P B Pencharz
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

7.  Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.

Authors:  Andrew S Day; Kylie E Whitten; Daniel A Lemberg; Cathy Clarkson; Maribel Vitug-Sales; Reuben Jackson; Tim D Bohane
Journal:  J Gastroenterol Hepatol       Date:  2006-10       Impact factor: 4.029

8.  Transient hypertransaminasemia in paediatric patients with Crohn disease undergoing initial treatment with enteral nutrition.

Authors:  Ellen Schatorjé; Hans Hoekstra
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-09       Impact factor: 2.839

9.  Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease.

Authors:  Kylie E Whitten; Steven T Leach; Timothy D Bohane; Helen J Woodhead; Andrew S Day
Journal:  J Gastroenterol       Date:  2009-12-03       Impact factor: 7.527

10.  [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].

Authors:  V M Navas-López; J Blasco-Alonso; S Lacasa Maseri; F Girón Fernández-Crehuet; M J Serrano Nieto; M I Vicioso Recio; C Sierra Salinas
Journal:  An Pediatr (Barc)       Date:  2014-04-02       Impact factor: 1.500

View more
  26 in total

1.  Individualized Food-Based Dietary Therapy for Crohn's Disease: Are We Making Progress?

Authors:  Dale Lee; David Suskind
Journal:  Dig Dis Sci       Date:  2016-04       Impact factor: 3.199

2.  Do Orally Administered Immunoglobulin-Based Agents Represent the Future of IBD Therapeutics?

Authors:  Jason M Shapiro; Basavaraj Kerur
Journal:  Dig Dis Sci       Date:  2015-07-17       Impact factor: 3.199

Review 3.  The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.

Authors:  James D Lewis; Lindsey Albenberg; Dale Lee; Mario Kratz; Klaus Gottlieb; Walter Reinisch
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

Review 4.  Inflammatory Bowel Disease in Primary Immunodeficiencies.

Authors:  Judith R Kelsen; Kathleen E Sullivan
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

Review 5.  Special Considerations of Anastomotic Leaks in Crohn's Disease.

Authors:  N Nimalan A Jeganathan; Walter A Koltun
Journal:  Clin Colon Rectal Surg       Date:  2021-10-01

6.  Children with Crohn's Disease Frequently Consume Select Food Additives.

Authors:  Dale Lee; C Kaiulani Swan; David Suskind; Ghassan Wahbeh; Jairam Vanamala; Robert N Baldassano; Mary B Leonard; Johanna W Lampe
Journal:  Dig Dis Sci       Date:  2018-06-04       Impact factor: 3.199

7.  Safety and Efficacy of Exclusive Enteral Nutrition for Percutaneously Undrainable Abdominal Abscesses in Crohn's Disease.

Authors:  Yibin Zhu; Liang Xu; Wei Liu; Weilin Qi; Qian Cao; Wei Zhou
Journal:  Gastroenterol Res Pract       Date:  2017-08-30       Impact factor: 2.260

Review 8.  The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review.

Authors:  Amber MacLellan; Jessica Moore-Connors; Shannan Grant; Leah Cahill; Morgan G I Langille; Johan Van Limbergen
Journal:  Nutrients       Date:  2017-05-01       Impact factor: 5.717

Review 9.  Recipe for IBD: can we use food to control inflammatory bowel disease?

Authors:  Mario Witkowski; Marco Witkowski; Nicola Gagliani; Samuel Huber
Journal:  Semin Immunopathol       Date:  2017-11-09       Impact factor: 9.623

Review 10.  Microbiome, Metabolome and Inflammatory Bowel Disease.

Authors:  Ishfaq Ahmed; Badal C Roy; Salman A Khan; Seth Septer; Shahid Umar
Journal:  Microorganisms       Date:  2016-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.